PZH-2111

N/A

Report date: 2024/12/19 16:31:40
NME

Base Information

Drug NamePZH-2111
Drug Alias NamePZH-2111PZH2111
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor receptor 2 inhibitorsFibroblast growth factor receptor 3 inhibitors
TargetsFibroblast growth factor receptor 2Fibroblast growth factor receptor 3
Therapy Area/IndicationsSolid tumoursCholangiocarcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesZhangzhou Pientzehuang Pharmaceutical Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesZhangzhou Pientzehuang Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumoursCholangiocarcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A